Cartessa Aesthetics, VAIM Bring JUVELOOK Skincare Serum to US Market
Key Takeaways
- Cartessa Aesthetics and VAIM have partnered to introduce JUVELOOK Skincare Serum to the US market, expanding access to Korean aesthetic skincare technology.
- JUVELOOK Skincare Serum combines poly-D,L-lactic acid (PDLLA) and hyaluronic acid (HA) in a topical formulation designed to complement aesthetic procedures, including laser resurfacing and radiofrequency microneedling.
- VAIM launched the JUVELOOK brand in 2019 and reports distributing its products in more than 60 countries, with more than 3 million vials sold globally.

Cartessa Aesthetics has announced an exclusive distribution partnership with South Korean medical aesthetics company VAIM to introduce JUVELOOK Skincare Serum to the United States. The topical formulation combines poly-D,L-lactic acid (PDLLA) and hyaluronic acid (HA) and is intended for professional skincare following aesthetic procedures.
Announced November 10, 2026, the agreement expands the availability of Korean aesthetic technology in the US market, particularly in post-procedure skincare following treatments such as radiofrequency (RF) microneedling and laser resurfacing.
What Is JUVELOOK Skincare Serum?
JUVELOOK Skincare Serum is a topical formulation combining PDLLA, a biodegradable and biocompatible polymer used in collagen-stimulating aesthetic treatments, with HA, an ingredient commonly used to support skin hydration.
According to VAIM, its proprietary PDLLA technology incorporates spherical particles with a porous internal structure designed for gradual biodegradation. The company has adapted its existing biomaterial technology into a topical product intended to complement in-office aesthetic procedures.
Although PDLLA is established in injectable biostimulation, the announcement did not provide clinical trial data demonstrating collagen stimulation or improved post-procedure outcomes with the topical serum.
Expanding Korean Aesthetic Technology in the US
VAIM launched the JUVELOOK brand in 2019 and reports distributing its products in more than 60 countries, with more than 3 million vials sold globally.
Under the partnership, Cartessa Aesthetics will serve as the exclusive US distributor of JUVELOOK Skincare Serum, expanding its portfolio beyond energy-based aesthetic devices into professional skincare.
The serum is now available to qualified aesthetic practices throughout the United States.
The introduction reflects growing interest in integrating regenerative-inspired skincare formulations into aesthetic treatment protocols.
Source
Cartessa Aesthetics. VAIM partners with Cartessa Aesthetics to bring Korea's leading biostimulator brand, JUVELOOK, to the U.S. marketplace. PR Newswire. Published November 10, 2026. https://www.prnewswire.com/news-releases/vaim-partners-with-cartessa-aesthetics-to-bring-koreas-leading-biostimulator-brand-juvelook-to-the-us-marketplace-302934602.html